Writing on the WallThe People Who Are Getting Rich By Profiting on Health CareThe rogue’s gallery of medical company CEOs who have gotten obscenely rich from price-gouging and denying claims18h ago
InCurated NewslettersbyLauren Grawert, MDThe Secret Solution for Sky Rocketing Drug CostsAre you ready for this?Jul 3122
Irum NawazDispensing is the core process in health care and other industriesMedications Dec 214Dec 214
Richard A MeyerEffective Strategies for Pharma Marketing SavingsMarketing is a vital component of the pharma industry, where competition is fierce, and products are often lifesaving. However, the costs…2d ago2d ago
InCareer PathsbyJames Bellerjeau, JD, MBAWhy Aren’t More Pharma Companies Nonprofits?The shareholder model is absurdly counterproductive in the case of pharma companiesDec 18, 202346Dec 18, 202346
Writing on the WallThe People Who Are Getting Rich By Profiting on Health CareThe rogue’s gallery of medical company CEOs who have gotten obscenely rich from price-gouging and denying claims18h ago
InCurated NewslettersbyLauren Grawert, MDThe Secret Solution for Sky Rocketing Drug CostsAre you ready for this?Jul 3122
Richard A MeyerEffective Strategies for Pharma Marketing SavingsMarketing is a vital component of the pharma industry, where competition is fierce, and products are often lifesaving. However, the costs…2d ago
InCareer PathsbyJames Bellerjeau, JD, MBAWhy Aren’t More Pharma Companies Nonprofits?The shareholder model is absurdly counterproductive in the case of pharma companiesDec 18, 202346
Irene NwaukwaBioequivalence Studies in Nigeria: A New Era for Pharmaceutical RegulationHow NAFDAC's new bioequivalence requirements will transform drug quality and reshape Nigeria's pharmaceutical futureDec 4
Bo BissettHow Big Pharma Capitalizes on Attempted Suicides and AddictionsOn November 29th, 2024, I, Bo Bissett, drove into a wooded lot past New River, Carteret County with the intent of ending my life. This is…4d ago
InWise & WellbyJohn Kruse MD, PhDPeople With Rare Conditions Deserve MedicationsBut are pharmaceutical companies abusing “Orphan Drug” rules?Dec 11, 202312
